Skip to main content
. 2023 Mar 29;115(6):628–635. doi: 10.1093/jnci/djad020

Figure 3.

Figure 3.

Timeline of newly approved medicines for patients with metastatic cancer per cancer type in the Netherlands. Gray dots, squares, and triangles show medicines for which the year of approval is uncertain (see Supplementary Table 10, available online). GIST = gastrointestinal stromal tumors; HNSCC = head and neck squamous cell carcinoma; NET = neuroendocrine tumor; NSCLC = non-small cell lung cancer; SCLC = small cell lung cancer.